Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine, Nature Biotechnology and Nature Reviews Drug Discovery.
December 2009
2009:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
News | News Features
News
Royal Institution faces cash crisis
The Royal Institution of Great Britain is the world's oldest scientific research organization, but it now faces a financial crisis that could bring its 200-year reign to an end.
Nature News (17 December 2009)
| Full Text |
UK research funding proposal is 'irresponsible'
Some of the UK's leading universities and researchers have condemned a scheme that would assess the economic and social benefits of research to help determine who wins a large fraction of university funding.
Nature News (17 December 2009)
| Full Text |
Hope for Japan's key projects
Japan's Council for Science and Technology Policy (CSTP) opposes the deep cuts in funding proposed by the Government Revitalization Unit (GRU).
Nature News (17 December 2009)
| Full Text |
Consent issue dogs stem-cell approval
The US expansion of federal funding for human embryonic stem-cell research is being hampered by details in consent forms.
Nature News (17 December 2009)
| Full Text |
French research wins huge cash boost
Universities in France are set to receive an €11-billion windfall as part of an initiative intended to boost the country's long-term competitiveness.
Nature News (17 December 2009)
| Full Text |
Cancer genomes reveal risks of sun and smoke
The genetic sequences of two types of cancer — skin cancer and small-cell lung cancer — have revealed that the genomes bear the hallmarks of their respective carcinogens: sun and smoke.
Nature News (16 December 2009)
| Full Text |
Hollywood gives biologists a helping hand
Computer programs such as those used to create animated movies could soon be helping cell biologists explain hypotheses, or even make new discoveries.
Nature News (11 December 2009)
| Full Text |
'Killer application' for protein synthesis is retracted
The retraction of two papers from the lab of prominent US chemist Peter Schultz is a setback for researchers trying to synthesize and study glycoproteins.
Nature News (10 December 2009)
| Full Text |
Israel weighs up new funding agency
Israeli scientists are on a quest to support basic research in their country by establishing a biomedical research funding agency and boosting funding by as much as tenfold.
Nature News (10 December 2009)
| Full Text |
Centre turns away from healing herbs
The US National Center for Complementary and Alternative Medicine (NCCAM) will shift its focus towards symptom management.
Nature News (10 December 2009)
| Full Text |
Groups say med school training must evolve
A report issued by the Association of American Medical Colleges (AAMC) and the Howard Hughes Medical Institute (HHMI) suggested that medical students should be taught how evolution by natural selection leads to the diversity of life on earth.
Nature Medicine News (December 2009)
| Full Text |
Industry tightens its purse strings
A survey of more than 2,000 life-science researchers across the US found that industry funding of their studies fell by 8% from 1995 to 2006.
Nature Medicine News (December 2009)
| Full Text |
Straight talk with...Warwick Anderson
Warwick Anderson, the chief executive of Australia's National Health and Medical Research Council (NHMRC), talks to Nature Medicine about his first three years in the job and the NHMRC's accelerated evolution.
Nature Medicine News (December 2009)
| Full Text |
Prostate clues in the genome
Genetic association studies have identified about 30 gene variants that are mildly associated with prostate cancer; however, whether the presence of these gene mutations can accurately predict risk remains an unanswered question.
Nature Medicine News (December 2009)
| Full Text |
US bioethics commission promises policy action
US President Barack Obama has created the Presidential Commission for the Study of Bioethical Issues, which is charged with recommending legislative and regulatory action on issues from genomics and behavioral research to intellectual property, scientific integrity and conflicts of interest in research.
Nature News (3 December 2009)
| Full Text |
British medical research chief quits midterm
Leszek Borysiewicz, the head of Britain's Medical Research Council (MRC), has announced that he will depart the MRC a year before his four-year term is due to expire to become vice-chancellor at the University of Cambridge, UK.
Nature News (3 December 2009)
| Full Text |
Japan budget threat sparks backlash
Japanese scientists have mobilized a huge national and international protest against the budget-slashing policies of their new government.
Nature News (3 December 2009)
| Full Text |
Dirty pigs beat disease
A study showing that dirty piglets pick up bacteria that help them to develop robust immune systems later in life provides support for the hygiene hypothesis, which suggests that a lack of exposure to microbes in early life can increase susceptibility to certain autoimmune disorders.
Nature News (3 December 2009)
| Full Text |
Targeting RNA: an emerging hope for treating muscular dystrophy
Oligonucleotide-mediated modulation of RNA transcription and translation might help address some of the genetic mutations underlying Duchenne muscular dystrophy.
Nature Reviews Drug Discovery News (December 2009)
| Full Text |
News Features
Genetics: Watching science at work
The Genomics Network — a network of social scientists in the UK — aims to bridge the gap between natural and social scientists by seeking better ways to study the work of biologists.
Nature News (17 December 2009)
| Full Text |
Human genomics: The genome finishers
Researchers are working hard to close the gaps, fix the errors and finally complete the human genome sequence.
Nature News (17 December 2009)
| Full Text |
Markers of dispute
PSA, a widely used marker for the early detection of prostate cancer, has recently come under fire for its high rate of false positives — but other viable biomarker tests may soon be developed.
Nature Medicine News (December 2009)
| Full Text |
Developing tools for stratified medicine
Establishing a common language for the stakeholders in stratified medicine — including drug developers, diagnostic companies, regulators and payers — could help tackle the complex challenges posed by biomarker-based drug development.
Nature Reviews Drug Discovery News (December 2009)
| Full Text |
|
